Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.3 | 6e-16 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-15 |
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.22 | 8e-14 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-13 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-12 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-12 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-12 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-11 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-11 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-10 |